Non-Resident Fathers Project Selects Four National Sites for Funding to Increase Father Involvement and Improve Outcomes in Chi... (americanhumane.org randyb@americanhumane...)

(Date:1/8/2009)...wswire-FirstCall/ -- Allscripts-Misys Healthcare,...lutions, Inc. (Allscripts or,the Company), today ...six,months ended November 30, 2008. , (Log...LLSCRIPTSLOGO-b ) , The Company,s results f...8,include results from legacy Allscripts for the ...

(Date:1/8/2009)...swire-USNewswire/ -- The Pew Charitable Trusts ann...ector, chemical and food safety programs, in its H...who was formerly deputy staff director and general...d Public Works, brings nearly 25 years of experien...o Pew. , , "We are excited to be joined by suc...

(Date:1/8/2009)...incipal. Christine Siu and Jason Brown, Ph.D. Pro...ANCISCO and STAMFORD, Conn., Jan. 8 /PRNewswire/ -...enture capital firm that invests in life science a...he promotion of three members of its investment te...hristine Siu and Jason Brown have been promoted to...

(Date:1/8/2009)...ewswire-USNewswire/ -- A proposal by the State of ...Children,s Home has prompted the 125,000-member Am...annual Mid-Winter conference January 10-12, 2009, ...early unanimous opposition to the proposal. , ,...,000 in direct and in-kind support to the home, is...

[0] Allscripts Reports Fiscal 2009 Second Quarter Results [0] Veteran Environmental Health Expert Erik D. Olson to Join Pew [0] Thomas, McNerney & Partners Promotes Three Members of Its Investment Team [0] Indiana American Legion to Organize, Launch Opposition to Closing of Children's Home

...nostic test for Bird Flu that will enable mass-scr...rate results within 24 hours. Named as RT-PCR test...results will be available in a day. Certainly a bl...e tests that are presently available to check for ...

...formulated a combination of drugs that could ward ...g time that new borns did not feel any pain. // B...research. The problem was how to stop this pain wi...f infants. Principal investigator Anna Taddio sa...

...han output is the key to weight loss a new study s...nes weight. // This study comes from the Canadian ...where we live, learn and work can help make or bre...eight gain. According to Elizabeth Gyorfi-Dyke, d...

...n’s, according to novel research, published in the... // The research team, as part of their study, dr...d 106 healthy people, belonging to the same age an...ons that sought to throw light on their personalit...

Other Medicine News:Health News:Location largely affects weight 2

Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu Relieving the Pain of Infants Location largely affects weight Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way

(Date:1/8/2009)...n an ongoing Phase Ib trial demonstrated a 2.5 log..., Conference Call Today at 8:30AM EST , , SAN...armaceuticals, Inc. (Nasdaq: ANDS ) today announ...ase Ib clinical trial of ANA598, the Company,s inv... ANA598 was very well-tolerated and demonstrated p...

(Date:1/7/2009)...ewswire/ -- Scientists have identified mutations i... in children with acute lymphoblastic leukemia (AL...research is needed to determine how changes in the...a relapse, the findings are likely to provide the ...sk of treatment failure. By using a molecular test...

(Date:1/7/2009)... ImQuest Life Sciences announced today the success...nd Drug Administration to initiate human clinical ...r IQP-0410. ImQuest anticipates initiating their P...410 is a novel small molecule inhibitor of HIV whi...criptase inhibitor (NNRTI). The compound possesses...

(Date:1/7/2009)...n Puhua Hospital Stem Cells Center ( http://www.st...stem cells to effectively treat neurological disor... additions to its medical and research staff that ...bilities for growing numbers of incoming internati...distinguished Dr. Jiang Ping, who was named Chief ...

Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2 ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3 ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4 ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5 ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6 Gene Abnormality Found to Predict Childhood Leukemia Relapse 2 Gene Abnormality Found to Predict Childhood Leukemia Relapse 3 Gene Abnormality Found to Predict Childhood Leukemia Relapse 4 Gene Abnormality Found to Predict Childhood Leukemia Relapse 5 Gene Abnormality Found to Predict Childhood Leukemia Relapse 6 ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2 Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2 Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3 Sharps Compliance Corp Announces Appointment of Al Aladwani as its Senior Vice President of Operations 14951 1 Sharps Compliance Corp Announces Appointment of Al Aladwani as its Senior Vice President of Operations 14951 2 Sharps Compliance Corp Announces Appointment of Al Aladwani as its Senior Vice President of Operations 14951 3 Risky teen behavior may not occur at home or school 3A but how to track 3F 14948 1 Risky teen behavior may not occur at home or school 3A but how to track 3F 14948 2 China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents 14944 1 China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents 14944 2 CMPMedica Expands SearchMedica com with Multiple Additional Vertical Search Applications co developed with Convera 28R 29 4144 1 CMPMedica Expands SearchMedica com with Multiple Additional Vertical Search Applications co developed with Convera 28R 29 4144 2 CMPMedica Expands SearchMedica com with Multiple Additional Vertical Search Applications co developed with Convera 28R 29 4144 3

[0] ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients [1] Gene Abnormality Found to Predict Childhood Leukemia Relapse [0] ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 [0] Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients

...E)--Jul 5, 2007 - Array BioPharma Inc.,(Nasdaq: AR...er,Robert E. Conway, will speak at the C.E Unterb...n New York City. The public is,welcome to particip...ay BioPharma website. -0-, ,Event: C.E Un...er: Robert E. Conway, Chief Executive Officer...

...UNSWICK, New Jersey, July 03, 2007,/PRNewswire-Fir...NA,company, announced today that J. Michael French...nterberg, Towbin Emerging Growth,Opportunities Con...e Mandarin Oriental Hotel in New York. , A live au...on,the "Investors" section of the company,s websit...

Other Medicine Technology:Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2

Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging,Growth Conference Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference

... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...

Medicine Products:

High Density Lipoprotein, A-1 Hg (Mercury), fingernails Hexosaminidase A & Total, Leukocytes Heterophile Antibody by Latex Agglutination with Reflex to Titer

Non-Resident Fathers Project Selects Four National Sites for Funding to Increase Father Involvement and Improve Outcomes in Chi...(americanhumane.org randyb@americanhumane...),Health